Center Hospital of the National Center for Global Health and Medicine

Tokyo, Shinjuku-ku 162-8655

0 studies enrolling now · 4 studies all time

What they study most

Chronic Kidney Disease, Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial

Studies at this site

• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) — Completed
• A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis — Completed